Zettamine Labs Profile
Key Indicators
- Authorised Capital ₹ 1.80 Cr
as on 30-07-2024
- Paid Up Capital ₹ 1.60 Cr
as on 30-07-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
as on 30-07-2024
- Revenue -6.22%
(FY 2023)
- Profit -83.25%
(FY 2023)
- Ebitda 105.41%
(FY 2023)
- Net Worth 32.64%
(FY 2023)
- Total Assets 24.45%
(FY 2023)
About Zettamine Labs
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.80 Cr and a paid-up capital of Rs 1.60 Cr.
The company currently has active open charges totaling ₹2.65 Cr.
Nageswaragupta Booragadda and Vanaja Akula serve as directors at the Company.
- CIN/LLPIN
U72501TG2018PTC123866
- Company No.
123866
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Begumpet, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zettamine Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nageswaragupta Booragadda  | Director | 16-Apr-2018 | Current |
| Vanaja Akula | Director | 16-Apr-2018 | Current |
Financial Performance of Zettamine Labs.
Zettamine Labs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.22% decrease. The company also saw a substantial fall in profitability, with a 83.25% decrease in profit. The company's net worth Soared by an impressive increase of 32.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zettamine Labs?
In 2023, Zettamine Labs had a promoter holding of 98.31% and a public holding of 1.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Apr 2023 | ₹1.50 M | Open |
State Bank Of India Creation Date: 01 Jun 2022 | ₹2.50 Cr | Open |
How Many Employees Work at Zettamine Labs?
Zettamine Labs has a workforce of 72 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zettamine Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zettamine Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
